Mpox vaccine study aims to unlock immune secrets

NCT ID NCT07499739

Recruiting now Knowledge-focused Sponsor: Institute of Tropical Medicine, Belgium Source: ClinicalTrials.gov ↗

First seen Apr 10, 2026 · Last updated May 23, 2026 · Updated 4 times

Summary

This study looks at how well the mpox vaccines MVA-BN and LC16m8 work by measuring immune responses in 300 vaccinated adults in the Democratic Republic of the Congo. Participants give blood samples over several months to see how long protection lasts. The goal is to better understand vaccine effectiveness, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MPOX are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

Centre Convivial Kasa-Vubu
RECRUITING

Kinshasa, Democratic Republic of the Congo

Contact Phone: •••-•••-•••• Email: •••••@•••••
Kinoise
NOT_YET_RECRUITING

Kinshasa, Democratic Republic of the Congo

Contact Phone: •••-•••-•••• Email: •••••@•••••
Kokolo
NOT_YET_RECRUITING

Kinshasa, Democratic Republic of the Congo

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

MPOX